U.S. markets closed

Inovio Pharmaceuticals, Inc. (GBMB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.3420-0.0180 (-5.00%)
At close: 08:04AM CET
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3600
Bid0.3460 x 30000
Ask0.3570 x 30000
Day's Range0.3420 - 0.3420
52 Week Range0.3140 - 1.7836
Avg. Volume2,087
Market Cap96.139M
Beta (5Y Monthly)0.99
PE Ratio (TTM)N/A
EPS (TTM)-0.5800
Earnings DateFeb 28, 2024 - Mar 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.22
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for GBMB.F

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • InvestorPlace

      The 3 Most Undervalued Biotech Stocks to Buy: November 2023

      These companies in the biotechnology sector are doing incredible work and achieving wonderful developments. The result is not not only growth and profit for the companies, but they are also offering excellent and efficient solutions for the health of each one of us. Personally, the biotechnology sector is one of my favorite sectors because it is always growing and developing. If you are as interested in these companies as I am, here are 3 undervalued biotech stocks to take a look at. Inovio (INO

    • Insider Monkey

      Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript

      Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript November 9, 2023 Inovio Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.13 EPS, expectations were $-0.13. Operator: Good afternoon, ladies and gentlemen and welcome to the Inovio Third Quarter 2023 Financial Results Conference Call. At this time all lines are in a listen-only […]

    • Motley Fool

      Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript

      Good afternoon, and thank you for joining the Inovio 2023 third quarter conference call. Joining me on today's call are Dr. Jackie Shea, president and CEO; Dr. Michael Sumner, chief medical officer; Mr.